<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Celltrion Healthcare presenteert positieve resultaten voor CT-P10, biosimilar rituximab, bij gevorderd folliculair lymfoom tijdens de American Society of Hematology Meeting 2018	</title>
	<atom:link href="https://www.novumpr.nl/2018/12/06/celltrion-healthcare-presenteert-positieve-resultaten-voor-ct-p10-biosimilar-rituximab-bij-gevorderd-folliculair-lymfoom-tijdens-de-american-society-of-hematology-meeting-2018/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/12/06/celltrion-healthcare-presenteert-positieve-resultaten-voor-ct-p10-biosimilar-rituximab-bij-gevorderd-folliculair-lymfoom-tijdens-de-american-society-of-hematology-meeting-2018/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=celltrion-healthcare-presenteert-positieve-resultaten-voor-ct-p10-biosimilar-rituximab-bij-gevorderd-folliculair-lymfoom-tijdens-de-american-society-of-hematology-meeting-2018</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Thu, 06 Dec 2018 08:11:52 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
